A Study of LY900014 in Participants With Type 1 Diabetes (PRONTO-T1D)

NCT03214367 PHASE3 COMPLETED Results posted

The main purpose of this study is to evaluate the efficacy of the study drug LY900014 compared to insulin lispro, both in combination with insulin glargine or insulin degludec, in adults with type 1 diabetes (T1D).

Details

Lead sponsor	Eli Lilly and Company
Phase	PHASE3
Status	COMPLETED
Enrolment	1392
Start date	Mon Jul 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Aug 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Type 1 Diabetes Mellitus

Interventions

• LY900014
• Insulin Lispro
• Insulin Glargine
• Insulin Degludec

Countries

Italy, Japan, Taiwan, Poland, New Zealand, Russia, Sweden, Mexico, United States, Slovakia, Greece, Austria, Argentina, Puerto Rico, Romania, Spain, Brazil, Germany, Australia, India